TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance

被引:41
作者
Zhao, Peiqi [1 ]
Li, Lanfang [1 ]
Zhou, Shiyong [1 ]
Qiu, Lihua [1 ]
Qian, Zhengzi [1 ]
Liu, Xianming [1 ]
Cao, Xuchen [2 ]
Zhang, Huilai [1 ]
机构
[1] Tianjin Med Univ, Dept Lymphoma,SinoUS Ctr Lymphoma & Leukemia, Tianjin Med Univ Canc Inst & Hosp,Tianjins Clin R, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, Tianjin 300060, Peoples R China
[2] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Minist Educ, Key Lab Canc Prevent & Therapy,Key Lab Breast Can, Tianjin 300060, Peoples R China
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2018年 / 84卷
基金
中国国家自然科学基金;
关键词
TPGS; P-gp inhibition; Multidrug resistance; Mesoporous silica nanoparticles (MSNs); Doxorubicin; UP-CONVERSION NANOPARTICLES; RESPONSIVE NANOPARTICLES; P-GLYCOPROTEIN; IN-VITRO; CANCER; DOXORUBICIN; NANOCARRIERS; INHIBITION; REVERSAL; SYSTEM;
D O I
10.1016/j.msec.2017.11.040
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Multidrug resistance (MDR) has become a very serious problem in cancer therapy. To effectively reverse MDR in tumor treatments, a new pH-sensitive nano drug delivery system (NDDS) composed of mesoporous silica nanoparticles (MSNs) and D-a-tocopheryl poly-ethylene glycol 1000 succinate (TPGS) copolymers was synthesized to deliver doxorubicin (DOX) into drug-resistant breast cancer cell line (MCF-7/ADR). DOX@MSNs-TPGS were characterized to have a single peak size distribution, high DOX loading efficiency and a pH-dependent drug release profile. MSNs-TPGS were internalized via caveolae, clathrin-mediated endocytosis and energy-dependent cellular uptake. The DOX@MSNs-TPGS exhibited 10-fold enhanced cell killing potency compared to free DOX and DOX@MSNs. The enhanced MDR reversal effect was ascribed to the higher amount of cellular uptake of DOX@MSNs-TPGS in MCF-7/ADR cells than that of free DOX and DOX@MSNs, as a result of the inhibition of P-gp mediated drug efflux by TPGS. In vivo studies of NDDS in tumor-bearing mice showed that DOX@MSNs-TPGS displayed better efficacy against MDR tumors in mice and reached the tumor site more effectively than DOX and DOX@MSNs, with minimal toxicity. These results suggest DOX@MSNs-TPGS developed in this study have promising applications to overcome drug resistance in tumor treatments.
引用
收藏
页码:108 / 117
页数:10
相关论文
共 49 条
[1]   Rational Design of Multi-Stimuli-Responsive Nanoparticles for Precise Cancer Therapy [J].
An, Xiaonan ;
Zhu, Aijun ;
Luo, Huanhuan ;
Ke, Hengte ;
Chen, Huabing ;
Zhao, Youliang .
ACS NANO, 2016, 10 (06) :5947-5958
[2]  
[Anonymous], ACS APPL MAT INTERFA
[3]  
[Anonymous], CHEMINFORM
[4]   The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins [J].
Bogman, K ;
Erne-Brand, F ;
Alsenz, J ;
Drewe, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (06) :1250-1261
[5]   Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS):: Conjugation chemistry, characterization, in vitro and in vivo evaluation [J].
Cao, Na ;
Feng, Si-Shen .
BIOMATERIALS, 2008, 29 (28) :3856-3865
[6]   Intracellular angiotensin II activates rat myometrium [J].
Deliu, Elena ;
Tica, Andrei A. ;
Motoc, Dana ;
Brailoiu, G. Cristina ;
Brailoiu, Eugen .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2011, 301 (03) :C559-C565
[7]   Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) [J].
Dintaman, JM ;
Silverman, JA .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1550-1556
[8]   pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells [J].
Dong, Da-Wen ;
Xiang, Bai ;
Gao, Wei ;
Yang, Zhen-Zhen ;
Li, Jing-Quan ;
Qi, Xian-Rong .
BIOMATERIALS, 2013, 34 (20) :4849-4859
[9]   Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP [J].
Dong, Xiaowei ;
Mattingly, Cynthia A. ;
Tseng, Michael T. ;
Cho, Moo J. ;
Liu, Yang ;
Adams, Val R. ;
Mumper, Russell J. .
CANCER RESEARCH, 2009, 69 (09) :3918-3926
[10]   Polymer conjugates as anticancer nanomedicines [J].
Duncan, Ruth .
NATURE REVIEWS CANCER, 2006, 6 (09) :688-701